Clinical Trials Logo

Neovascularization, Pathologic clinical trials

View clinical trials related to Neovascularization, Pathologic.

Filter by:

NCT ID: NCT05677685 Completed - Clinical trials for Diabetic Macular Edema

VISUPRIME® Eye Drops

Start date: June 22, 2023
Phase: N/A
Study type: Interventional

The study purpose is to assess the efficacy of VISUPRIME® eye drops in preventing the conjunctival bacterial load in patients undergoing to anti-VEGF injection.

NCT ID: NCT05662943 Completed - Clinical trials for Age-Related Macular Degeneration

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Start date: December 5, 2022
Phase:
Study type: Observational

The purpose of the present study was to evaluate the outcomes of type 1 macular neovascularization (MNV), including polypoidal choroidal vasculopathy in patients treated tolerating subretinal fluid (SRF) using Aflibercept in a clinical setting. Approximately 150 patients are anticipated to be enrolled in this study. SRF is a primary type of fluid compartment prevalent in type 1 aneurysmal MNV. In a recent study, the prevalence of SRF during 24-month follow-up period was 36.7% to 38.8% in type 1 MNV and polypoidal choroidal vasculopathy (PCV), 20.0% in type 2 MNV, and 7.7% in type 3 MNV. In addition, patients with SRF showed better visual prognosis in type 1 MNV/PCV. For this reason, type 1 MNV is an appropriate candidate for evaluating the influence of tolerating SRF.

NCT ID: NCT05659940 Recruiting - Clinical trials for Corneal Neovascularization

Correlation Between a Novel Subset of Neutrophil and Corneal Neovascularization.

Start date: January 1, 2023
Phase:
Study type: Observational

The purpose of this study is to determine whether a novel subset of neutrophils is correlated with corneal neovascularization in the patients suffered from ocular chemical injury.

NCT ID: NCT05650047 Recruiting - Clinical trials for Retinal Neovascularization

Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD

Start date: September 9, 2022
Phase:
Study type: Observational

During the last 25 years, OCT has become one of the most common imaging technologies used to diagnose and monitor retinal diseases, including AMD. The OCT self-imaging capabilities of the Notal Vision Home OCT (NVHO) system for retinal fluid visualization in the central 10 degrees were validated during several prospective clinical studies1,2,3,4,5. This study is designed to evaluate the retinal fluid exposure of eyes with NV-AMD, using the NVHO system to guide therapy.

NCT ID: NCT05628792 Not yet recruiting - Bone Vascular Tumor Clinical Trials

In Vivo Depiction Of Bone Vascularization With UHR-CT CT And Deep Learning Algorithm Reconstruction: A Preliminary Study

Start date: December 20, 2022
Phase:
Study type: Observational

To evaluate the image quality and ability to depict in vivo bone vascularization with an ultra-high-resolution computed tomography (UHR-CT) scanner using a deep learning reconstruction (DLR) and hybrid iterative reconstruction (HIR) algorithms, compared to simulated conventional CT, using osteoid osteoma (OO) as a model.

NCT ID: NCT05627999 Recruiting - Clinical trials for Haemorrhoidal Bleeding

Trans-anal Eco-doppler Evaluation of Haemorrhoidal Vascularization After Percutaneous Hemorrhoidal Artery Embolization. A Pilot Study.

Start date: January 19, 2023
Phase:
Study type: Observational

To evaluate the usefulness of endoanal ultrasound in the evaluation of emorrhoidal artery embolization outcomes

NCT ID: NCT05494775 Recruiting - Clinical trials for Diabetic Retinopathy

Effect of Corona Virus on Intravitreal Injections

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

During pandemic of corona virus, patients compliance may be affected. We aim to study the factors lead to unregulated visits and its implications on the final visual outcome.

NCT ID: NCT05416385 Recruiting - Clinical trials for Cardiovascular Diseases

Carotid Intraplaque Neovascularization Combined With Stress Echo

CIRCE
Start date: August 16, 2021
Phase:
Study type: Observational

The root cause of heart attacks and strokes is atherosclerosis, the hardening and thickening of blood vessels due to the presence of "plaque" which is a build-up of fat and cholesterol in the walls of vessels. To diagnose heart disease, patients receive a stress test to find out if they require surgery. Up to 52% of patients receiving an angiogram (surgery) to look at plaque blockages in the heart are found to be normal (no blockage). Patients who are suspected of having heart disease often undergo a stress test, which helps cardiologists decide if the patient has heart disease, but stress tests can give false results. In Ontario alone, 90% are stress tests are found to be normal and patients are sent home with little follow-up. Of these 3-5% (~4,000 patients/year) will have a major cardiovascular event (heart attack, surgery, or death) within 3 years. We need to improve the stress test accuracy to reduce cardiac outcome. We now know that it is not just the total amount of plaque that leads to heart attacks and strokes, but the composition of the plaque that can lead to breakage causing a heart attack. Plaques are soft and fragile, and typically contain fat and small leaky blood vessels within their cores. If we are able to identify patients that have leaky plaques using ultrasound, we may be able to improve the accuracy of stress testing. We propose a study looking at the combination of stress testing (assessing heart function) and neck ultrasound (assessing plaque composition), to identify patients at risk for cardiovascular events (heart attacks and death). We will enrol patients from 6 sites across Canada and follow-them for cardiac outcome for 3 years.

NCT ID: NCT05328076 Active, not recruiting - Thyroid Cancer Clinical Trials

Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography

ANGIO_PARA
Start date: May 2, 2022
Phase:
Study type: Observational

Prospective, observational, single-center study about the use of indocyanine green angiography during total thyroidectomy. The main objective of the study is to identify a quantitative score of parathyroid vascularization as an outcome of angiography that correlates with the absence of postoperative hypoparathyroidism. It is planned to enroll 66 patients.

NCT ID: NCT05295563 Completed - Cerebral Palsy Clinical Trials

Effects of Repeated Botulinum Toxin Injections in Children With Cerebral Palsy

Start date: May 1, 2021
Phase:
Study type: Observational

One of the disorders observed in children with cerebral palsy (CP) is abnormal muscle tone, and the most common tone problem is spasticity. Botulinum toxin A (BoNT-A) injections are frequently used to reduce spasticity in CP rehabilitation. BoNT-A injections can be administered as a single dose, and some patients require repeated injections. The aim of this study was to examine the effects of repeated BoNT-A applications applied to the gastrocnemius muscle of children with CP on muscle morphology and functionality.